Patients focused on metabolic optimization will need to work closely with their physicians to identify alternative interventions, such as lifestyle modifications, FDA-approved medications, and other evidence-based therapies
Absorption is lower than injection, but the peptide reaches target dermal tissue directly and there's no needle
In SURMOUNT-1 , a 72-week Phase 3 double-blind trial in 2,539 adults with obesity (or overweight with a complication) but without diabetes, once-weekly tirzepatide produced mean weight changes of 15.0% (5 mg), 19.5% (10 mg), and 20.9% (15 mg) versus 3.1% with placebo, with 5057% of participants on the higher doses losing at least 20% of body weight
Czechia Greater than 99.8 % purity confirmed by COA Assay content verified at 22.6 mg Endotoxin level below 0.001 EU/mg No detectable heavy metals or microbial contamination High-purity peptide for controlled laboratory research For research use only not for human or veterinary use For laboratory research only